Status: affected by circulating vaccine-derived poliovirus type 2 (cVDPV2)
Senegal is affected by cVDPV2, linked to an outbreak originating in Nigeria. GPEI partners, including through our regional and country offices, are continuing to assist Egyptian health authorities in conducting a complete investigation, including to ascertain more clearly the origin/source of the isolated virus, and assess potential risk of spread within the country as well as internationally.
Polio this week in Senegal
- One case of circulating vaccine-derived poliovirus type 2 (cVDPV2) was reported in Diourbel bringing the number of 2021 cases to three.
- Read our Senegal page for more information.
International Health Regulations
Countries affected by poliovirus circulation are subject to temporary recommendations issued by the Emergency Committee of the International Health Regulations on Poliovirus, under the auspices of the Public Health Emergency of International Concern. The latest report by the Committee is as of February 2021.
WHO’s International Travel and Health recommends that all travellers to polio-affected areas be fully vaccinated against polio. Residents (and visitors for more than 4 weeks) from infected areas should receive an additional dose of OPV or inactivated polio vaccine (IPV) within 4 weeks to 12 months of travel.